Sharekhan's research report on Cholamandalam Investment and Finance Company
Credit cost (cal as avg. AUM) declined to 1.1% (vs 1.3% q-o-q) on improvement in the assets quality. GS3 ratio declined to 2.82% as compared to 2.96% in previous quarter. AUM grew at healthy rate of 40% y-o-y/8% q-o-q to Rs. 134 bn (in line with our estimate). Disbursements growth, however, slowed down to 4% q-o-q (vs 7.6% q-o-q in last quarter) due to low growth in new businesses. At CMP, the stock trades at P/BV 4.2x/3.4x to its FY2025E/FY2026E BV estimates.
Outlook
We reiterate our Buy rating on stock with an unchanged PT of Rs. 1,425. PAT grew by 28% y-o-y/15% q-o-q to Rs. 876 crore (4% higher than our estimate) led by lower credit cost. Other income is likely to remain high as the company received insurance brokerage license.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Cholamandalam Investment and Finance Company - 3012024 - khan
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
